BELLICUM PHARMACEUTICALS, INC Contracts & Agreements

Amendment to Consulting Agreement by and between the Company and Richard A. Fair, effective as of December 31, 2023 (Filed With SEC on February 23, 2024)

Asset Purchase Agreement, dated as of November 21, 2023, by and among Bellicum Pharmaceuticals (Filed With SEC on November 22, 2023)

Amendment to Consulting Agreement, dated as of September 26, 2023, by and between the Registrant and Charity Scripture (Filed With SEC on November 14, 2023)

Amendment to Consulting Agreement by and between the Company and Charity D. Scripture, dated September 26 (Filed With SEC on September 29, 2023)

Consulting Agreement by and between the Registrant and Richard A. Fair, dated June 30, 2023 (Filed With SEC on August 10, 2023)

Consulting Agreement by and between the Registrant and Charity D. Scripture, dated June 30, 2023 (Filed With SEC on August 10, 2023)

Description of (Filed With SEC on March 31, 2023)

Bellicum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended (Filed With SEC on March 31, 2023)

Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on August 11, 2022)

Bellicum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended (Filed With SEC on June 16, 2022)

Master Services Agreement Between The University of Texas M. D. Anderson Cancer Center and Bellicum Pharmaceuticals, Inc (Filed With SEC on March 24, 2022)

Employment Agreement by and between the Registrant and Charity Scripture, dated December 1, 2021 (Filed With SEC on March 24, 2022)

Form of pre-funded warrant issued in December 2021 private placement (Filed With SEC on December 6, 2021)

Form of accompanying common warrant issued in December 2021 private placement (Filed With SEC on December 6, 2021)

Securities Purchase Agreement, dated December 4, 2021, by and among the Company and the purchasers named therein (Filed With SEC on December 6, 2021)

License Agreement by and between the Registrant and BioVec Pharma, Inc., dated as of June 4, 2015 (Filed With SEC on August 12, 2021)

Bellicum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended (Filed With SEC on June 17, 2021)

Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on May 14, 2021)

Forms of stock option grant notice, stock option agreement and notice of exercise, and forms of restricted stock award notice and restricted stock award agreement under the... (Filed With SEC on March 31, 2021)

Amended and Restated License Agreement (Filed With SEC on November 5, 2020)

Omnibus Amendment Agreement, dated October 3, 2014, by and between Registrant and ARIAD Pharmaceuticals, Inc (Filed With SEC on November 5, 2020)

Exclusive License Agreement, dated March 20, 2008, by and between the Registrant and Baylor College of Medicine (Filed With SEC on November 5, 2020)

Exclusive License Agreement, dated June 27, 2010, by and between the Registrant and Baylor College of Medicine (Filed With SEC on November 5, 2020)

Cancer Research Grant Contract, dated July 27, 2011, by and between the Registrant and the Cancer Prevention and Research Institute of Texas (Filed With SEC on November 5, 2020)

Exclusive License Agreement, effective November 1, 2014, by and between the Registrant and Baylor College of Medicine (Filed With SEC on November 5, 2020)

Underwriting Agreement, dated October 29, 2020, by and between Bellicum Pharmaceuticals and H.C. Wainwright & Co (Filed With SEC on November 2, 2020)

Form of pre-funded warrant (Filed With SEC on November 2, 2020)

Form of warrant to purchase common stock (Filed With SEC on November 2, 2020)

Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on August 6, 2020)

Bellicum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended (Filed With SEC on August 6, 2020)

Second Amendment to Loan and Security Agreement, dated March 31, 2020, by and between the Registrant and Oxford Finance LLC (Filed With SEC on May 7, 2020)

Description of Securities (Filed With SEC on March 12, 2020)

Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2020)

First Amendment to Loan and Security Agreement, dated December 24, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 12, 2020)

First Amendment to Asset Purchase Agreement, dated February 21, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 12, 2020)

Forms of stock option grant notice, stock option agreement and notice of exercise, and forms of restricted stock award notice and restricted stock award agreement under the... (Filed With SEC on March 12, 2020)

Asset Purchase Agreement, dated January 17, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 12, 2020)

Underwriting Agreement, dated August 16, 2019, by and among the Company, Jefferies LLC and Wells Fargo Securities, LLC, as representative of the several underwriters identified... (Filed With SEC on August 19, 2019)

Form of Warrant issued in public offering (Filed With SEC on August 19, 2019)

Form of Warrant issued in private placement (Filed With SEC on August 19, 2019)

Securities Purchase Agreement, dated August 16, 2019, by and among the Company and the institutional investors named therein (Filed With SEC on August 19, 2019)

Supply Agreement by and between Registrant and Miltenyi Biotech GmbH, dated March 27, 2019 (Filed With SEC on May 7, 2019)

Bellicum Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 7, 2019)

Bellicum Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 12, 2019)

Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2019)

Employment Agreement by and between Registrant and Rosemary Williams, effective January 1, 2017 (Filed With SEC on March 12, 2019)

Employment Agreement by and between Registrant and Atabak Mokari, effective November 19, 2018 (Filed With SEC on March 12, 2019)

Employment Agreement by and between Registrant and Aaron Foster, Ph.D., effective June 1, 2016 (Filed With SEC on March 12, 2019)

Open Market Sale AgreementSM, dated October 5, 2018, by and between Bellicum Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on October 5, 2018)

Separation Agreement by and between Registrant and Alan Musso, dated July 13, 2018 (Filed With SEC on August 7, 2018)

Retention Agreement by and between Registrant and Rosemary Williams, dated July 17, 2018 (Filed With SEC on August 7, 2018)

Employment Agreement by and between Registrant and Shane M. Ward, effective May 29, 2018 (Filed With SEC on August 7, 2018)

Underwriting Agreement, dated April 17, 2018, among Bellicum Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Jefferies LLC, as representatives for the several underwriters (Filed With SEC on April 18, 2018)

Bellicum Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 13, 2018)

Form of Stock Option Grant Notice and Option Agreement under the 2014 Equity Incentive Plan (Filed With SEC on March 13, 2018)

Form of Stock Option Grant Notice and Option Agreement under the 2014 Equity Incentive Plan (with accelerated vesting) (Filed With SEC on March 13, 2018)

Form of Restricted Stock Award Notice and Restricted Stock Award Agreement under the 2014 Equity Incentive Plan (Filed With SEC on March 13, 2018)

Form of Restricted Stock Unit Notice and Restricted Stock Unit Agreement under the 2014 Equity Incentive Plan (Filed With SEC on March 13, 2018)

Form of Stock Option Grant Notice and Option Agreement under the 2014 Equity Incentive Plan (Inducement Award) (Filed With SEC on March 13, 2018)

Form of Stock Option Grant Notice and Option Agreement under the 2014 Equity Incentive Plan (Non-Employee Director Form) (Filed With SEC on March 13, 2018)

Incentive Award Program, as amended on February 19, 2018 (Filed With SEC on March 13, 2018)

Employment Agreement by and between registrant and William Grossman, effective February 5, 2018 (Filed With SEC on March 13, 2018)

Loan and Security Agreement by and between the Registrant and Oxford Finance LLC dated as of December 21, 2017 (Filed With SEC on March 13, 2018)

Letter agreement by and between the registrant and Alan A. Musso, effective August 3, 2017 (Filed With SEC on November 7, 2017)

Cancer Research Grant Contract with the Cancer Prevention and Research Institute of Texas, dated August 9, 2017 (Filed With SEC on November 7, 2017)

Employment Agreement by and between registrant and Gregory Naeve, effective July 27, 2017 (Filed With SEC on November 7, 2017)

EXHIBIT A CLOSING RELEASE AND WAIVER OF CLAIMS DO NOT SIGN PRIOR TO THE SEPARATION DATE TO BE SIGNED AND RETURNED ON THE SEPARATION DATE OR WITHIN 21 DAYS THEREAFTER ------ (Filed With SEC on August 8, 2017)

BELLICUM PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2017)

BELLICUM PHARMACEUTICALS, INC. AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on May 8, 2017)

5,000,000 Shares Bellicum Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 24, 2017)

BELLICUM PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 4, 2014 APPROVED BY THE STOCKHOLDERS: DECEMBER 5, 2014 AMENDED AND APPROVED... (Filed With SEC on March 13, 2017)

RESEARCH COLLABORATION AGREEMENT (Filed With SEC on March 13, 2017)

CO-DEVELOPMENT AND CO-COMMERCIALISATION AGREEMENT BETWEEN ADAPTIMMUNE LIMITED AND BELLICUM PHARMACEUTICALS, INC. (Filed With SEC on March 13, 2017)

BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2017)

FIFTH AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 9, 2016)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 9, 2016)

SECOND AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 9, 2016)

BELLICUM PHARMACEUTICALS, INC. CONSULTING AGREEMENT (Filed With SEC on August 8, 2016)

BELLICUM PHARMACEUTICALS, INC. SPONSORED RESEARCH AGREEMENT NO. 2 (Filed With SEC on August 8, 2016)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 8, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 9, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 14, 2016)

BELLICUM PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 14, 2016)

LEASE AGREEMENT LIFE SCIENCE PLAZA 2130 WEST HOLCOMBE BOULEVARD HOUSTON, TEXAS BY AND BETWEEN SHERIDAN HILLS DEVELOPMENTS L.P. (LANDLORD) AND BELLICUM PHARMACEUTICALS, INC.... (Filed With SEC on March 14, 2016)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 14, 2016)

LICENSE AGREEMENT (Filed With SEC on August 13, 2015)

LEASE AGREEMENT LIFE SCIENCE PLAZA 2130 WEST HOLCOMBE BOULEVARD HOUSTON, TEXAS BY AND BETWEEN SHERIDAN HILLS DEVELOPMENTS L.P. (LANDLORD) AND BELLICUM PHARMACEUTICALS, INC.... (Filed With SEC on August 13, 2015)

BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2015)

BELLICUM PHARMACEUTICALS, INC. AMENDED & RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 7, 2015)

BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 7, 2015)

Bellicum Pharmaceuticals, Inc. DESCRIPTION OF INCENTIVE AWARD PROGRAM (Filed With SEC on February 27, 2015)

[Number of Shares] Bellicum Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2014)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on December 9, 2014)

BELLICUM PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 4, 2014 APPROVED BY THE STOCKHOLDERS:DECEMBER 5, 2014 IPO DATE:[ ], 2014 (Filed With SEC on December 9, 2014)

BELLICUM PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on December 9, 2014)

BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on December 9, 2014)

SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 18, 2014)

INVESTOR RIGHTS AGREEMENT BETWEEN BELLICUMPHARMACEUTICALS, INC. AND ARIAD GENE THERAPEUTICS, INC. AND ARIADPHARMACEUTICALS, INC. (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE SERIES C PREFERRED STOCK (Filed With SEC on November 18, 2014)

COMMON STOCK PURCHASE WARRANT OF BELLICUMPHARMACEUTICALS, INC. (Filed With SEC on November 18, 2014)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 18, 2014)

BELLICUMPHARMACEUTICALS, INC. 2006 STOCK OPTION PLAN (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. 2011 STOCK OPTION PLAN (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:[ ], 2014 APPROVED BYTHE STOCKHOLDERS: [ ], 2014 IPODATE: [ ], 2014 (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. THIRD AMENDED & RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. AMENDED & RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2014)

AMENDMENT 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2014)

NOTICE OF EXPANSION OF LICENSED FIELD TO OBTAIN ADDITIONAL EXCLUSIVE RIGHTS (Filed With SEC on November 18, 2014)

AMENDED ANDRESTATED LICENSE AGREEMENT (Filed With SEC on November 18, 2014)

OMNIBUSAMENDMENT AGREEMENT (Filed With SEC on November 18, 2014)

EXCLUSIVELICENSE AGREEMENT BAYLOR COLLEGE OF MEDICINE BELLICUM PHARMACEUTICALS, INC. (Filed With SEC on November 18, 2014)

EXCLUSIVELICENSE AGREEMENT Re: BCM BLG # 13-040 Entitled Methods for Inducing Selective Apoptosis (Filed With SEC on November 18, 2014)

LEASE AGREEMENT LIFESCIENCE PLAZA 2130 WEST HOLCOMBE BOULEVARD HOUSTON, TEXAS BY ANDBETWEEN SHERIDAN HILLS DEVELOPMENTS L.P. (LANDLORD) AND BELLICUMPHARMACEUTICALS, INC. (TENANT)... (Filed With SEC on November 18, 2014)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 18, 2014)

SECOND AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 18, 2014)

THIRD AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 18, 2014)

FOURTH AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 18, 2014)

PROMISSORY NOTE (Filed With SEC on November 18, 2014)

BELLICUM PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on November 18, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 18, 2014)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 18, 2014)

Category

Industry

Companies

Contracts

BELLICUM PHARMACEUTICALS, INC Contracts & Agreements